Search
Search Results
##search.searchResults.foundPlural##
-
-
How I treat acute and persistent sickle cell pain
2041PDF: 1148HTML: 650 -
A SEROPREVALENCE OF HBV, HCV AND HIV-1 AND CORRELATION WITH MOLECULAR MARKERS AMONG MULTI-TRANSFUSED THALASSEMIA PATIENTS IN WESTERN INDIA Incidence of serology & molecular of HIV, HBV and HCV in thalassemia patients
1423PDF: 780HTML: 538 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2115PDF: 793HTML: 3254 -
ACUTE LUNG INJURY COMPLICATING BLOOD TRANSFUSION IN POST-PARTUM HEMORRHAGE: INCIDENCE AND RISK FACTORS.
2524PDF: 1285HTML: 3615Acute lung injury complicating blood transfusion in post-partum hemorrhage: incidence and risk factors.: 433 -
BACK TO THE “GOLD STANDARD”: HOW PRECISE IS HEMATOCRIT DETECTION TODAY? Novel ImageJ-based approach for the precise hematocrit measurement
2425PDF: 891HTML: 875 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4647PDF: 1975HTML: 18090 -
MOLECULAR MECHANISMS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA Guest Editor: Giancarlo Costaman
3466PDF: 1650HTML: 642 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9276PDF: 6180HTML: 88044Fig.1b: 211Fig.1c: 218Fig.2a: 202Fig.2b: 197Fig.4: 225Fig.2c: 201Fig.3: 205Tab.1: 255Tab.2: 233Tab.3: 216Tab.4: 249Fig1a: 212 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2654PDF: 834HTML: 5367 -
APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE
2658PDF: 1001HTML: 15129 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1447HTML: 634PDF: 868 -
PERPHERAL BLOOD CELL MITOCHONDRIAL DYSFUNCTION IN MYELODYSPLASTIC SYNDROMECAN BE IMPROVED BY A COMBINATION OF COENZYME Q10 AND CARNITINE Blood cell mitochondrial dysfunction in myelodysplastic syndrome
1214PDF: 807HTML: 370 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
8203PDF: 4402HTML: 7546 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
4053PDF: 1084HTML: 3895Untitled: 187Cneo. Fig.1: 122Untitled: 114Untitled: 144Untitled: 148 -
NURSING MANAGEMENT OF HAEMORRHAGIC CYSTITIS IN PATIENTS UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION: A MULTICENTRE ITALIAN SURVEY Nursing management of haemorrhagic cystitis
2040PDF: 1079HTML: 313 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2898PDF: 1875HTML: 3800Pellagatti Fig 1: 237Pellagatti Fig. 2: 231 -
GROUP-BASED TRAJECTORY MODELING OF PLATELET IN PATIENTS WITH APLASTIC ANEMIA: A STUDY BASED ON THE MIMIC DATABASE
1065PDF: 1052Suppl. Files: 656HTML: 182 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2318PDF: 1232HTML: 3893 -
-
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2898PDF: 1045HTML: 5636 -
THERAPEUTIC GENE EDITING FOR HEMOGLOBINOPATHIES Gene therapy for Hemoglobinopathies.
2278PDF: 1352Html: 330 -
POST-TRANSPLANT RELAPSE IN ACUTE LEUKEMIA: COMPARATIVE VALUE OF MRD AND CHIMERISM.
1137PDF: 589Suppl. Files: 136HTML: 458 -
STUDY OF SERUM HAPTOGLOBIN LEVEL AND ITS RELATION TO ERYTHROPOIETIC ACTIVITY IN BETA THALASSEMIA CHILDREN .
2300PDF: 1194HTML: 2603Study of serum haptoglobin level in thalassemia: 376Figures: 202 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
4893PDF: 1878HTML: 2182 -
Measurement of erythrocyte lifespan using a CO breath test in patients with thalassemia and the impact of treatment erythrocyte lifespan in patients with thalassemia
820PDF: 581HTML: 204 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
3091PDF: 1628HTML: 362







